Scinai Immunotherapeutics Ltd. (SCNI)
0.4844
+0.04
(+9.84%)
USD |
NASDAQ |
Nov 09, 16:00
0.479
-0.01
(-1.11%)
After-Hours: 19:36
Scinai Immunotherapeutics Total Assets (Quarterly) : 15.70M for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 15.70M |
| June 30, 2026 | 17.17M |
| March 31, 2026 | 17.59M |
| December 31, 2025 | 11.63M |
| September 30, 2025 | |
| June 30, 2025 | 11.84M |
| March 31, 2025 | |
| December 31, 2024 | 13.45M |
| September 30, 2024 | 12.26M |
| June 30, 2024 | 14.85M |
| March 31, 2024 | 17.05M |
| December 31, 2023 | 17.47M |
| September 30, 2023 | 18.58M |
| June 30, 2023 | 19.90M |
| March 31, 2023 | 23.29M |
| December 31, 2022 | |
| September 30, 2022 | 21.01M |
| June 30, 2022 | 24.43M |
| March 31, 2022 | 29.94M |
| December 31, 2021 | 32.00M |
| September 30, 2021 | 25.12M |
| June 30, 2021 | 27.02M |
| March 31, 2021 | 28.41M |
| December 31, 2020 | 17.72M |
| September 30, 2020 | 21.90M |
| Date | Value |
|---|---|
| June 30, 2020 | 24.76M |
| March 31, 2020 | |
| December 31, 2019 | 33.51M |
| September 30, 2019 | 34.33M |
| June 30, 2019 | 21.24M |
| March 31, 2019 | 27.38M |
| December 31, 2018 | 28.32M |
| September 30, 2018 | 22.21M |
| June 30, 2018 | 16.63M |
| March 31, 2018 | 20.53M |
| December 31, 2017 | 23.53M |
| September 30, 2017 | 23.69M |
| June 30, 2017 | 11.79M |
| March 31, 2017 | 11.46M |
| December 31, 2016 | 7.824M |
| September 30, 2016 | 8.624M |
| June 30, 2016 | 9.368M |
| March 31, 2016 | 10.20M |
| December 31, 2015 | 10.62M |
| September 30, 2015 | 11.40M |
| June 30, 2015 | 12.04M |
| March 31, 2015 | 4.116M |
| December 31, 2014 | 4.744M |
| September 30, 2014 | 5.379M |
| June 30, 2014 | 6.319M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Compugen Ltd. | 138.36M |
| Pluri, Inc. | 24.88M |
| Evogene Ltd. | 13.44M |
| CollPlant Biotechnologies Ltd. | 7.197M |
| Regentis Biomaterials Ltd. | -- |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 4.984M |
| Shareholders Equity (Quarterly) | 10.71M |
| Debt to Equity Ratio | 0.3166 |
| Current Ratio | 1.225 |
| Net Debt Paydown Yield | -10.78% |